G Castaneda-Hernandez
Overview
Explore the profile of G Castaneda-Hernandez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez-Romero V, Cruz-Antonio L, Franco-Bourland R, Guizar-Sahagun G, Castaneda-Hernandez G
Spinal Cord
. 2013 Oct;
51(12):936.
PMID: 24145688
No abstract available.
2.
Rodriguez-Romero V, Cruz-Antonio L, Franco-Bourland R, Guizar-Sahagun G, Castaneda-Hernandez G
Spinal Cord
. 2013 Apr;
51(7):528-31.
PMID: 23608810
Study Design: Laboratory investigation in rats submitted to experimental spinal cord injury (SCI). Objective: To characterize changes in renal function during acute SCI. Methods: Sprague Dawley rats were subjected to...
3.
Szabo S, Bibby M, Yuan Y, Donato B, Jimenez-Mendez R, Castaneda-Hernandez G, et al.
Ann Hepatol
. 2012 Sep;
11(5):623-35.
PMID: 22947522
Chronic infection with hepatitis C virus (HCV) is a major and growing public health concern worldwide, including in Latin America. With more efficacious therapies becoming available, decision-makers will require accurate...
4.
Villa M, Gonzalez R, Garcia-Roca P, Hernandez A, Ortiz L, Castaneda-Hernandez G, et al.
Proc West Pharmacol Soc
. 2012 Mar;
54:66-8.
PMID: 22423584
Mycophenolate mofetil is an immunosuppressive pro-drug frequently used to prevent renal graft rejection. It is hydrolyzed by esterases to obtain the active drug mycophenolic acid (MPA). There is high inter-patient...
5.
Cruz-Antonio L, Arauz J, Franco-Bourland R, Guizar-Sahagun G, Castaneda-Hernandez G
Spinal Cord
. 2012 Mar;
50(8):632-5.
PMID: 22410846
Study Design: Laboratory investigation in rats submitted to experimental spinal cord injury (SCI). Objective: To determine the effect of acute SCI on the pharmacokinetics of diclofenac, a marker drug of...
6.
Reyes H, Hernandez A, Valverde S, Cataneo A, Mendoza A, Barrera I, et al.
Pediatr Transplant
. 2010 Apr;
14(6):746-52.
PMID: 20412508
The aim of the study was to evaluate the efficacy and safety of the conversion of MMF to EC-MPS in pediatric renal transplant recipients. We included 12 patients with stable...
7.
Gil-Flores M, Ortiz M, Castaneda-Hernandez G, Chavez-Pina A
Methods Find Exp Clin Pharmacol
. 2010 Apr;
32(2):101-5.
PMID: 20401346
Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of acute gout and inflammation. However, its use is limited due to side effects. Acemetacin is a prodrug of...
8.
Esquivel A, Gonzalez-Ramirez R, Alberu J, Gracida C, Medeiros M, Castaneda-Hernandez G
Transplant Proc
. 2010 Feb;
42(1):353-6.
PMID: 20172348
Enteric-coated tablets containing mycophenolate sodium have been developed to reduce gastric toxicity. The objective of this study was to compare 2 enteric-coated formulations containing 360 mg of mycophenolate sodium: the...
9.
Vasquez-Bahena D, Salazar-Morales U, Ortiz M, Castaneda-Hernandez G, Troconiz I
Br J Pharmacol
. 2009 Dec;
159(1):176-87.
PMID: 19958362
Background And Purpose: This study establishes a pharmacokinetic/pharmacodynamic (PK/PD) model to describe the time course and in vivo mechanisms of action of the antinociceptive effects of lumiracoxib, evaluated by the...
10.
Baiza-Duran L, Quintana-Hau J, Tornero-Montano R, Ortiz M, Castaneda-Hernandez G, Alanis-Villarreal L, et al.
Int J Clin Pharmacol Ther
. 2009 Feb;
47(2):89-95.
PMID: 19203564
A novel topical ophthalmic formulation of the preferential COX-2 inhibitor meloxicam has recently been developed. The purpose of the present study was to evaluate the efficacy and safety of this...